NSEGeneral Updates31 Jul 2026 · 31 Jul 2026, 06:18 pm

General Updates

Sun Pharmaceutical Industries Limited · SUNPHARMA

✦ AI SummaryMgmt Change

Sun Pharmaceutical Industries Limited concluded its Board Meeting held on 31 July 2026, which commenced at 10:50 A.M. and concluded at 3:40 P.M.

Analysis Scores

Earnings Impact5/10

Growth Catalyst5/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk5/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Conclusion of the Board Meeting held today, i.e., 31 July 2026

Attachments (1)

📄

SUNSEC_31072026181812_BM_Outcome_31_July_2026_-_2.pdf

pdf

Download →

View document text

Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 31 July 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Conclusion of the Board Meeting held today, i.e., 31 July 2026 Further to our earlier communication dated 31 July 2026, this is to inform that the meeting of the Board of Directors of the Company held today commenced at 10:50 A.M., was adjourned for a break, and subsequently resumed and concluded at 3:40 P.M. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives.